Karius
Redwood City
About Karius
Karius is a life sciences company focused on generating genomic insights for infectious diseases with a liquid biopsy for infectious diseases. The Karius Test that helps clinicians make rapid, treatment decisions. By mapping each patient’s microbial landscape from a single blood draw, Karius moves closer to a vision of a world where infectious disease is no longer a major threat to human health. The Karius laboratory is CLIA-certified and CAP-accredited to perform high-complexity clinical laboratory testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $354.0M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2024)
- Website: kariusdx.com
- Phone: (866)452-7487
Industries & Categories
Biotechnology, Genetics, Health Care, Information Technology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/karius-19421 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.